Crown Electrokinetics Corp. Announces Intent to Voluntarily Delist from Nasdaq

NYSE - LSE

RBGPF	-19.57%	69	$
CMSC	-0.11%	22.845	$
RYCEF	1.89%	15.9	$
VOD	0.71%	14.765	$
AZN	1.04%	187.74	$
BCE	-0.84%	25.615	$
NGG	2.34%	84.305	$
RELX	-0.45%	32.315	$
GSK	3.4%	54.815	$
RIO	0.93%	87.588	$
BTI	1.12%	58.415	$
BCC	1.67%	74.82	$
JRI	2.71%	12.19	$
BP	1.72%	45.575	$
CMSD	0.31%	22.7	$

Crown Electrokinetics Corp. Announces Intent to Voluntarily Delist from Nasdaq

THINGS TO KNOW 23.07.2025

LOS ANGELES, CA / ACCESS Newswire / July 23, 2025 / Crown Electrokinetics Corp. (Nasdaq:CRKN) ("Crown" or the "Company") today announced that its Board of Directors approved the commencement of the process to voluntarily delist its securities from the Nasdaq Stock Market LLC ("Nasdaq") and its intention to file a Form 25 Notification of Delisting with the Securities and Exchange Commission (the "SEC"), which will remove the Company's common stock, par value $0.001 (the "common stock"), from listing and registration on Nasdaq. Nasdaq previously suspended the trading of the Company's common stock on March 5, 2025 due to noncompliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) and notified the Company that a Form 25 would be filed. However, as Nasdaq has not yet made the filing, the Company is doing so voluntarily.

Text size:

About Crown

Crown is a leading provider of innovative technology infrastructure solutions that benefit communities and the environment. Operating across multiple businesses - Smart Windows and Construction - Crown is developing and delivering cutting edge solutions that are challenging the status quo and redefining industry standards. For more information, please visit www.crownek.com.

Forward-Looking Information
Certain statements in this news release may be "forward-looking statements" (within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995) regarding future events or Crown's future financial performance that involve certain contingencies and uncertainties, including those discussed in Crown's Annual Report on Form 10-K for the year ended December 31, 2024, and subsequent reports Crown files with the U.S. Securities and Exchange Commission from time to time, in the sections entitled "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations." Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions, or any other statements relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates and projections about our business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and are likely to, differ materially from what is expressed or forecasted in forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date of this news release and Crown Electrokinetics Corp. undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this news release.

This press release does not constitute a public offer of any securities for sale. Any securities offered privately will not be or have not been registered under the Act and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

Contact Information:

Investor Relations
[email protected]

Public Relations
[email protected]

SOURCE: Crown Electrokinetics Corp.

View the original press release on ACCESS Newswire

F.Ramirez--AT

Featured

Goat vs gecko: A tiny Caribbean island faces wildlife showdown

Prince Silver Files NI 43-101 Technical Report for Its Stampede Gap Porphyry Copper-Gold-Molybdenum Project in Nevada

Triera Biosciences - a Zentek Company - Launches Contract Research Organization Services for Custom Aptamer Discovery, Biosensor Enablement, and Machine-Learning Classification

Arizona Tribune - Crown Electrokinetics Corp. Announces Intent to Voluntarily Delist from Nasdaq